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ABSTRACT 
Objective: Mimosa pigra roots are used in traditional medicine in the treatment of fever, headaches and cold. This study investigated the ethanol 
extract of the root of Mimosa pigra for its analgesic and anti-inflammatory activities in albino rats.  
Methods: The analgesic activity was evaluated by radiant heat tail flick method while the anti-inflammatory effect was investigated using fresh egg albumin 
induced paw edema in rats. The plant extract was evaluated at 250 mg/kg and 500 mg/kg. All administrations were done through the oral route. 
Results: Preliminary phytochemical screening showed that the extract contains; steroids, tannins, flavonoids, phlobatanins, saponins. The LD50 was 
found to be greater than 5000 mg/kg. The results showed that oral administration of 250 mg/kg of Mimosa pigra showed significantly (P<0.05) 
analgesic activity in30, 60 and 150 minutes while 500 mg/kg produced significantly (P<0.05) analgesic activity in 30, 60, 120 and 150 minutes. The 
two tested doses (250 mg/kg and500 mg/kg) were found to produce percentage inhibition of rat paw edema (42.60% and 49%) at 150 minutes 
compared to the positive control group of 63.20%.  
Conclusion: The findings of this study showed that the ethanol extract of this plant possesses significant anti-inflammatory and analgesic activities.  
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INTRODUCTION 
Plants have important roles as sources of prescription drugs in western 
medicine and their active constituents also serve as templates for 
synthetic drug optimization and provide intermediates that are used in 
the production of semi-synthetic drugs. All over the world, hundreds of 
higher plants are cultivated for substances useful in medicine and 
pharmacy [1]. In 2001,the researchers identified 122 compounds used in 
modern medicine, which were derived from "ethnicmedical" plant 
sources; 80% of these have had an ethnic medical use identical or related 
to the current use of the active elements of the plant [2]. Today, scientists 
are using these renewable resources to produce a new generation of 
therapeutic solutions. Thus, providing treatments for a lot of diseases 
such as hypertension, diabetes, cancer, fibrosis, spinal cord injuries, 
hepatitis, arthritis, inflammation and pains. Inflammation is a protective 
response and a part of the complex biological response of vascular 
tissues to harmful stimuli, such as pathogens, damaged cells, or irritants 
[3]. Without inflammation, wounds and infections would never heal. 
Inflammation is normally closely regulated by the body because 
progressive destruction of the tissue would compromise the survival of 
the organism [4]. 
Pain is the most common reason for physician consultation in the 
United States [5]. It is a major symptom in many medical conditions, 
and can significantly interfere with a person's quality of life and 
general functioning [6]. The roots of Mimosa pigra are sniffed for 
head colds, fever and headache in traditional medicine. The roots are 
also used traditionally in the treatment of asthma. In Sumatra, 
roasted and ground mimosa leaves are made into an infusion, which 
is drunk to treat a weak heart or weak pulse [7]. Literature revealed 
that anti-inflammatory and analgesic studies have not been reported 
for the root of this plant. 
Therefore, this study aims to evaluate the anti-inflammatory and 
analgesic activities of the ethanol extract of the root of Mimosapigra Linn.  
MATERIALS AND METHODS 
Plant material 
The root of the plant was collected from Chaza village in Suleja, 
Niger State by Mallam Mu’azan of National Institute for 
Pharmaceutical Research and Development (NIPRD) Abuja. The 
plant was identified and authenticated in the herbarium of the same 
institute by Jemilat Ibrahim, a staff of the same institute where a 
voucher specimen (NIPRD/H/6405) has been deposited in the 
herbarium. 
Extraction of plant material 
The roots of Mimosa pigra Linn were washed under a running tap to 
remove debris, then sliced into smaller pieces and air-dried under 
ambient condition. The air-dried root was pulverized by grinding 
using a mechanical grinder and stored in air tight container. 
Thereafter, 1 kg of the coarse powder of air-dried root was subjected 
to solvent extraction by maceration for 72 hours using 96% ethanol 
(Sigma-Aldrich, Germany). The extract was concentrated using the 
rotary evaporator and carefully evaporated to dryness over a water 
bath at a temperature of 40 °C. The percentage yield was then 
determined. The extract was stored in a refrigerator until use. 
Animals used 
Albino rats (150-200 g) of both sexes were obtained from the animal 
house of the Department of Pharmacology, Faculty of Basic Medical 
sciences, University of Port Harcourt. All animals were housed in 
cages (5 in each cage) in the animal house of the Department of 
Pharmacology, Faculty of Pharmaceutical Sciences, University of 
Port Harcourt. The animals were fed with the standard diet and 
water ad libitum and were deprived of food and water overnight 
prior to the experiment. All the standard ethical requirements for 
experimental animals were complied with. 
Experimental protocols 
Phytochemical screening 
Phytochemical screening was carried out on the ethanol extract of 
the Mimosa pigra root for the detection of various plant constituents 
according to the protocol of [8]. 
Acute toxicological evaluation 
A total of eighteen albino rats of either sex weighing 150-200g were 
used in the determination of the acute toxicity of the root of Mimosa 
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pigra Linn. The animals were randomly allotted into six groups of 
three animals each and the first three groups were treated with 10 
mg/kg, 100 mg/kg and 1,000 mg/kg of Mimosa pigra extract 
respectively, after 14 days of adaptation. The animals were treated 
via the oral route. They were observed frequently on the day of 
treatment for 24 hours for signs of toxicity or adverse effects and 
death. After 24 hours, no animal died, nor showed any sign of 
adverse effect. Subsequent doses of 1,600 mg/kg, 2,900 mg/kg and 
5,000 mg/kg of the plant extract was administered to the other three 
groups of three animals each and observed as above [9].  
Evaluation of analgesic activity 
Tail flick test 
The animals were divided into four groups of five animals each. The 
tail flick latency of the rats was assessed with Ugo Basile tail-flick 
analgesiometer. Group 1 animals was administered with 0.5 ml of 
distilled water, group 11 animals received 25 mg/kg aspirin while 
groups 111 and 1V were given 250 mg/kg and 500 mg/kg of the 
extract respectively. All administrations were done through the oral 
route by means of a canal. An infra-red (IR) intensity of 50 and cutoff 
time of the 60s was fixed to avoid tissue damage. The site of 
application of radiant heat in the tail was maintained at 1.5 cm, 
measured from the tip of the tail. The initial reading was taken 
immediately before administration of test and standard drugs and 
then 30, 60, 90, 120 and 150 minutes after treatment. The 
withdrawal time of the tail from the radiant heat source (in seconds) 
was taken as the reaction time or tail flick latency. The difference in 
tail flick latency or mean increase in latency after drug 
administration was used to indicate the analgesia produced by the 
test and standard drugs [10]. 
Evaluation of anti-inflammatory activity 
Egg albumin induced paw edema test 
The animals were divided into four groups of five animals of either 
sex each. Oral route of administration used for treatment. 0.5 ml of 
distilled water was administered to the negative control group 
(group A), 10 mg/kg of indomethacin was administered to the 
positive control group (group B) and groups C and D were treated 
with 250 mg/kg and 500 mg/kg of plant extract respectively. Thirty 
minutes after treatments, acute inflammation was induced by 
intraplantar administration of 0.1 ml of fresh egg albumin in the 
right hand paw of the animals [11]. Paw volume of rats was 
measured prior to administration of egg albumin and after at 
predetermined intervals of 30 minutes for 150 minutes using 
vernier caliper. The change in paw volume was measured using 
vernier caliper and anti-inflammatory activity calculated [12]. 
Percentage inhibition of paw thickness was calculated using the 
formula:  
 
Where tCn = paw thickness of particular time point of control 
animals, 
tCo= paw thickness before induction;  
tTn = paw thickness of particular time point of treated animals,  
tTo = paw thickness before induction. 
Statistical analysis 
The results were expressed as mean±SEM. Statistical analysis of data 
was done using one-way analysis of variance (ANOVA) followed by 
student’s t-test. The statistical analysis was done to determine the 
significance of difference between the control groups and the 
treated groups. P-values˂0.05 was considered to be statistically 
significant. 
 
Table 1: Phytochemical screening 
Chemical constituents Observation 
 Alkaloids  ˍ 
 Tannins  + 
 Anthraquinones   ˍ 
 Phlobatannins  + 
 Flavonoids  + 
 Triterpenes  + 
 Saponins  + 
+shows the presence of chemical constituent, ˗ shows the absence of 
chemical constituent 
 
Table 2: Analgesic activity of ethanol extract of Mimosa pigra root by tail flick method (mean±Standard Error of Mean) 
Groups Dose Mg/kg TIME (minute)±SEM 
0 30 60 90 120 150 
Distilled water 0.5 ml 5.26±0.72  4.78±0.84  4.14±1.08  3.64±0.63   4.40±0.68  4.45±0.45 
Aspirin 25 6.90±0.84 6.94±1.07* 5.50±0.44* 5.50±0.6* 5.14±0.68 5.10±0.45  
Extract  250 5.30±0.84 5.18±1.30* 4.46±0.90* 3.80±0.41 4.32±0.68 4.56±0.32* 
Extract  500 6.78±0.80 6.54±0.77* 5.60±0.90* 4.44±0.39 5.56±0.59* 5.18±0.79* 
Values are expressed as mean±SEM, n=5 
* P<0.05statistically significant values when compared with the control group and the standard drug. 
 
Table 3: Effect of ethanol extract of Mimosa pigra root on egg albumin induced rat paw edema. Mean paw size measured in (mm±Standard 
Error of Mean) with percentage inhibition of rat paw edema 
Groups Dose 
Mg/kg 
 Time (minute)±SEM 
0 30 60 90 120 150 


















































Values are expressed as mean±SEM, n=5,  
*P<0.05 statistically significant values when compared with the control group and the standard drug. 
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RESULTS 
Preliminary phyto chemical screening revealed the presence of 
steroids (triterpenes), tannins, flavonoids, phlobatannins, saponins 
most of which are phenolic compounds (table 1). The acute toxicity 
study of the ethanol extract of the root of Mimosa pigra showed no 
adverse effect or mortality even at 5000 mg/kg.  
A comparison was made between the control and the treated groups 
and between the standard and the treated groups. From the results 
obtained, oral administration of 250 mg/kg of Mimosa pigra showed 
significant (P˂ 0 . 05) analgesic activity in 30, 60, and 150 minutes, 
while oral administration of 500 mg/kg produced significant (P˂ 0 . 
05)analgesic activity in 30, 60,120 and 150 minutes when compared 
with the control group and the standard drug (aspirin) (table 2). 
The plant extract at 250 mg/kg significantly (P˂0 . 05) inhibited 
acute inflammation caused by egg albumin induced paw edema at 
60, 90 and 150 minutes, while 500 mg/kg of the plant extract 
showed significant (P˂ 0 . 05) inhibition of rat paw edema at time 
intervals of 60, 90 120 and 150 minutes when compared with the 
control group and indomethacin. 
The ethanol extract of Mimosa pigra inhibited egg albumin induced 
paw oedema in a dose dependent manner. Oral administration of 
250 mg/kg of the extract showed significant (P˂0 . 05) percentage 
inhibition of egg induced rat paw edema at 60, 90 and 150 minutes 
when compared with the negative control group and indomethacin, 
while 500 mg/kg dose showed significant (P˂0. 05) inhibition at 60, 
90, 120 and 150 minutes when compared with the distilled water 
and the standard drug, but exhibited a greater percentage inhibition 
than indomethacin at 60 and 90 minutes, respectively as shown in 
table 3. However, the results showed that the percentage inhibition 
of paw edema by the two doses of the extract increased with 
increase in time, even though the 500 mg/kg extract exhibited a 
higher percentage inhibition when compared to that of 250 mg/kg 
dose. At 90 minutes, indomethacin (31.0%), 250 mg/kg and 500 
mg/kg of the extract showed 33.14% and 38.60% percentage 
inhibition of edema which could be said to be comparable. 
DISCUSSION 
Medicinal plants are believed to be an important source of new 
chemical substances with potential therapeutic efficacy [13]. 
The acute toxicity study of the ethanol extract of the root of Mimosa 
pigra showed no adverse effect or mortality even at 5000 mg/kg, 
thus, it can be considered to be relatively safe [9]. 
The ethanol extract of Mimosa pigra root showed significant 
analgesic and anti-inflammatory activities. 
An analgesic is any member of the group of drugs used to achieve 
analgesia, relief from pain by acting on the peripheral and central 
nervous system. The tail flick assay is the method for measuring 
centrally mediated analgesic activity [10]. Mimosa pigra root extract 
increased tail flick latency towards the radiant heat source in a dose 
dependent manner. This corresponds to the reports of [14] that the 
leaf extract of Phlogacanthus thyrsi florus showed significant central 
analgesic activity (P<0.05). The results obtained in this study also 
corroborates that of [10] which reported that percentage of 
inhibition of Cassia auriculata extract was found to be statistically 
significant in comparison to control (aspirin) in the tail flick assay. 
The analgesic effect of this plant extract may be mediated through 
inhibition of cyclooxygenase and/or lipo oxygenase (and other 
inflammatory mediators) [15] 
Inflammation is the response of living tissue to injury which involves 
activation of various enzymes, mediator release, cell migration, 
tissue breakdown and repair. Egg albumin-induced paw edema in 
rats is an in vivo model of inflammation used to screen agents for 
anti-inflammatory effect [16]. 
Chemical mediators such as histamine, serotonin (5-HT), kinins and 
prostanoids mediate an acute inflammation induced by phlogistic 
agents such as fresh egg albumin [17]. Mimosa pigra root ethanol 
extract showed a significant inhibitory effect on rat paw edema in 
the middle phase and the late phase of egg albumin–induced 
inflammation. Carrageenan (egg albumin)-induced paw edema 
model in rats is known to be sensitive to cyclooxygenase inhibitors 
and has been used to evaluate the effect of non-steroidal anti-
inflammatory agents, which primarily inhibit the cyclooxygenase 
involved in prostaglandin synthesis [18]. 
Indomethacin acts by inhibiting the cycloxygenase 2 (COX-2) which 
converts arachidonic acid to prostaglandins, histamines, kinnins 
which are mediators of inflammation. Thus, the anti-inflammatory 
activity of the plant may be attributed to its ability to inhibit 
prostaglandins, histamine, leucotrienes (mediators of inflammation). 
Since flavonoids are known to inhibit the enzyme prostaglandin 
synthetase, more specifically the endoperoxidase [19]. 
The findings of this anti-inflammatory study corresponds to the 
report of [20] that hydro-acetone extracts of Lannea microcarpa 
fruit and leaves inhibited acute inflammation. 
The observed analgesic and anti-inflammatory activity of Mimosa 
pigra may likely be due to the presence of phytochemical 
constituents such as flavonoids, tannins, saponins and triterpenes. 
This is because antinociceptive and inflammatory activities of many 
plants have been attributed to plant constituents such as flavonoids 
[21], tannins [22] and triterpenes [23]. 
CONCLUSION 
The results obtained from this study have shown that the root 
extract of Mimosa pigra seems to possess both analgesic activity and 
anti-inflammatory activities which is dose dependent and contains 
bioactive constituents. Further studies could be done to isolate the 
active principles and elucidate the mechanism of action of the 
biologically active constituents. 
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